17 Oct 2025 | 3 Mins Read
Natco Pharma shares surge on Supreme Court greenlight
Flipitmoney
Shares of Natco Pharma Ltd. gained up to 3% on Friday, October 17, after the Supreme Court dismissed a plea by Roche, challenging the interim Delhi High Court Order on the roll out of the generic version of the Risdipalm, a Spinal Muscular Atrophy treatment drug, for ₹15,900, compared to Roche's imported price of ₹6 lakh.